Knee Osteoarthritis
A practical guide to non-surgical regenerative options for knee osteoarthritis, including PRP and stem cell therapy, and how Dr. Bhandari approaches each case in Bellevue, WA.
What Is Knee Osteoarthritis?
Knee osteoarthritis is a degenerative joint disease in which articular cartilage progressively breaks down, the joint space narrows, and the surrounding tissue responds with chronic low-grade inflammation that drives pain and stiffness. At Dr. Bhandari's Bellevue practice, knee osteoarthritis is the most common condition treated with non-surgical regenerative therapies.
The structural changes of knee OA extend beyond cartilage alone. Subchondral bone, the dense bone just beneath the cartilage layer, undergoes remodeling, developing sclerosis and cysts as it absorbs forces the cartilage can no longer buffer. The synovial membrane, which lines the joint and produces lubricating fluid, becomes chronically inflamed, contributing to swelling, warmth, and a joint environment not conducive to healing. Over time, osteophytes (bone spurs) form at the joint margins.
Patients typically present with pain that worsens with loading activities, including walking, climbing stairs, or rising from a chair, paired with morning stiffness that improves with motion. Gradually, over years, they experience a reduction in comfortable range of motion. The condition disproportionately affects patients over 50, but earlier onset is common in those with prior knee injuries, ligamentous instability, or metabolic and inflammatory drivers. At Dr. Bhandari's practice in Bellevue, WA, knee osteoarthritis is the most common complaint for which patients seek out non-surgical regenerative treatments. However, this is consistent across the Pacific Northwest as well as the rest of the country. There is an ever-growing population of individuals looking for alternatives to cortisone injections and joint replacement surgeries, and that is exactly what Dr. Bhandari offers in his practice.
What Are the Standard Conventional Treatments for Knee Osteoarthritis?
Conventional treatment for knee osteoarthritis follows a stepwise approach: activity modification and weight management, physical therapy for strength and mechanics, NSAIDs for pain and inflammation, and corticosteroid or hyaluronic acid injections when oral medications are insufficient. These approaches address symptoms rather than the underlying joint environment, which is where Dr. Bhandari's regenerative orthopedic care differs.
Physical therapy can meaningfully improve muscle support around the joint and reduce the load on articular surfaces, and it remains an important component of any knee OA management plan. NSAIDs such as ibuprofen or naproxen reduce inflammatory pain but are not designed for long-term use and carry gastrointestinal, renal, and cardiovascular risks with extended use. Corticosteroid injections provide short-term symptomatic relief and are widely used. Hyaluronic acid injections (viscosupplementation) aim to restore some of the lubricating properties of synovial fluid, which can be helpful for mild cases in the short term. When conservative measures no longer provide adequate relief and joint degeneration is severe, total or partial knee replacement surgery becomes the conventional endpoint.
Why Do Conventional Treatments Often Fall Short?
Conventional treatments manage the symptoms of knee osteoarthritis without addressing the biological environment that is driving the degeneration. For patients wanting to avoid surgery and maintain function and quality of life, this distinction is critical. For those in Bellevue and the greater Seattle area, this is exactly what Dr. Bhandari focuses on through his regenerative approach to knee osteoarthritis.
Corticosteroid injections are one of the clearest examples. While cortisone can provide short-term pain relief, multiple studies have raised concern that repeated intra-articular cortisone, a strong anti-inflammatory medicine, is associated with accelerated cartilage loss and subchondral bone changes over time, the opposite of what a degenerating knee joint needs. NSAIDs mask inflammatory pain without resolving the underlying joint environment that is generating it, and their long-term use introduces systemic risks that do not improve the knee itself. Joint replacement surgery is an appropriate and effective intervention for end-stage OA, but it is a last resort that carries with it a risk of peri-procedure mortality that is greater than zero, and recovery can be prolonged and incomplete for many patients.
What is often missing from the standard of care is an approach that asks: why is this joint degenerating, and what can be done to support its own capacity to repair? Dr. Bhandari's integrative naturopathic framework starts with that question. Beyond structural imaging, a full clinical assessment includes metabolic contributors, inflammatory burden, hormonal status, and biomechanical factors that may be accelerating degeneration, none of which are addressed by a cortisone injection or a pill. The comprehensive pain management assessment is often where this evaluation begins.
Can PRP Help with Knee Osteoarthritis?
Platelet-rich plasma (PRP) therapy has one of the strongest evidence bases of any orthobiologic intervention for knee osteoarthritis. Delivering a concentrated dose of the patient's own growth factors directly into the joint may support cartilage repair, reduce synovial inflammation, and shift the joint environment from chronic degeneration toward active healing. Dr. Bhandari delivers PRP under real-time ultrasound guidance with lab-verified dosing.
What PRP Does for Knee OA Specifically
The knee joint in osteoarthritis is characterized by a chronically degraded biological environment: high concentrations of catabolic enzymes that break down cartilage, reduced anabolic signaling, and a synovial fluid composition that no longer supports tissue maintenance. Intra-articular PRP delivers concentrated growth factors, including PDGF, TGF-β, IGF-1, and VEGF, that counteract this environment. When injected, activated platelets trigger an acute inflammatory response followed by an anti-inflammatory healing cascade, the same two-phase sequence the body uses to complete tissue repair. These growth factors stimulate chondrocyte (cartilage cell) activity, modulate synovial inflammation, and support the recruitment of resident stem cells within the joint.
Clinically, patients with knee OA treated with PRP commonly report reduced pain with walking and stairs, improved joint comfort at rest, and a reduction in morning stiffness, improvements that develop gradually over two to six months as the biological healing response progresses. PRP does not reverse severe structural damage, but evidence suggests it may slow the rate of progression and provide meaningful functional improvement, particularly in mild to moderate OA.
Research Evidence
A randomized controlled trial published in Scientific Reports (Bansal et al., 2021) enrolled 150 patients with knee osteoarthritis and compared PRP formulated to an absolute platelet count of 10 billion with hyaluronic acid over one year. The PRP group showed significant improvements in WOMAC and IKDC outcome scores and six-minute pain-free walking distance, alongside reductions in inflammatory markers compared to the hyaluronic acid group. The authors concluded that achieving a minimum absolute platelet count is critical for long-term chondroprotective efficacy, underscoring the importance of lab-verified, dose-controlled PRP preparation. A separate trial published in Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders (Raeissadat et al., 2015) found that patients treated with PRP showed significantly greater pain reduction and functional improvement at one year compared to hyaluronic acid, with no serious adverse events. PRP is now among the most studied orthobiologic interventions for knee osteoarthritis, with a growing body of literature supporting its role in the mild to moderate disease range.
Dr. Bhandari's Approach to PRP for Knee OA
Not all PRP is the same: preparation protocol, platelet concentration, and delivery accuracy each significantly affect outcomes. Before every PRP treatment, Dr. Bhandari orders lab testing to establish the patient's individual baseline. The PRP preparation is then processed and concentrated precisely to target the optimal therapeutic range for that particular concern. This lab-verified dosing process is not standard practice at most regenerative orthobiologic clinics.
Delivery is performed under real-time ultrasound guidance. The needle is visualized throughout its path into the knee joint space, and the injection is confirmed on-screen before the PRP is released, a meaningful difference from palpation-guided (blind) injections, which do not offer the same level of accuracy and introduce unnecessary risk. When a neurogenic component is contributing to knee pain, as it often does in chronic OA cases involving sensitized genicular or infrapatellar nerve branches, Dr. Bhandari may integrate perineural injection therapy alongside PRP to address both the structural and neurogenic drivers of pain.
Does Stem Cell Therapy Work for Knee Osteoarthritis?
For advanced knee osteoarthritis, autologous adipose-derived stem cell therapy offers a broader regenerative response. Mesenchymal stem cells, perivascular cells, and immunomodulatory factors from the patient's own adipose tissue can support cartilage regeneration and joint environment restoration in ways growth factors alone cannot. Dr. Bhandari offers the most advanced form of this procedure at his Bellevue clinic.
What Adipose-Derived Stem Cell Therapy Does for Knee OA
Adipose tissue (fat) is one of the richest sources of mesenchymal stem cells in the human body. When processed using Dr. Bhandari's approach, a same-day, in-office harvest under local anesthesia processed into microfat and nanofat fractions, the resulting cellular preparation contains mesenchymal stem cells (MSC's) capable of differentiating into chondrocyte-like cells, perivascular cells that support vascular repair in the joint, and potent immunomodulatory factors that can reset the chronic inflammatory environment of an arthritic knee.
For knee OA specifically, this cellular diversity matters. Advanced cartilage loss involves not only degraded tissue but a fundamentally altered joint environment, one in which the chronic inflammatory milieu actively suppresses healing. MSC-rich adipose-derived therapy can modulate this environment rather than simply deliver growth signals into it, making it a more appropriate option for cases that have progressed beyond what PRP alone can address.
Research Evidence
Research published in Stem Cells (Jo et al., 2014) demonstrated that intra-articular mesenchymal stem cell injection for knee osteoarthritis produced significant improvements in pain scores and functional outcomes, with cartilage regeneration observed on MRI at 24 weeks in higher-dose groups. A systematic review published in the Journal of Clinical Orthopaedic Trauma (Zampogna et al., 2024) analyzed seven clinical trials comprising 339 treated knees in patients over 65 with knee osteoarthritis, evaluating autologous adipose-derived stem cell therapies including stromal vascular fraction, cultured adipose-derived stem cells, and the MAT procedure. All seven trials reported improvement across validated outcome measures, including KOOS, WOMAC, and VAS pain scales, and the authors concluded that this treatment approach is effective and safe in this patient population, supporting its consideration for elderly patients with treatment-resistant knee osteoarthritis who do not have end-stage disease. The adipose-derived route is of particular interest because of its high MSC yield and the fact that the same procedure provides the tissue source and therapeutic product without a separate marrow harvest.
Dr. Bhandari's Approach to Stem Cell Therapy for Knee OA
Dr. Bhandari uses exclusively autologous adipose-derived cellular therapy: cells harvested from the patient's own fat tissue, same day, in the clinic. The primary distinction from commercially marketed "stem cell" products is one of mislabeling: those products are typically donor-derived growth factor concentrates rather than true stem cell preparations. Dr. Bhandari's approach uses only the patient's own tissue, as adipose-derived cellular therapy contains several different cell types, growth factors, and other beneficial signaling molecules that an umbilical or embryonic commercial product cannot replicate.
The tissue harvest is performed under local anesthesia and does not require general anesthesia or an operating room. The collected adipose tissue is processed into MFAT and delivered under real-time ultrasound guidance into the knee joint space on the same day. As with all injection treatments in this practice, the patient always sees Dr. Bhandari personally, from initial consultation through the harvest and injection treatment itself.
When Are Multiple Therapies Combined for Knee Osteoarthritis?
Knee osteoarthritis is rarely a single-tissue problem, and treatment plans at Dr. Bhandari's Bellevue clinic reflect that complexity. PRP and adipose-derived stem cell therapy address the cartilage and joint environment, but the full picture of knee OA often includes contributions from sensitized local nerves, lax periarticular ligaments, and systemic inflammatory or metabolic factors that benefit from a broader regenerative strategy.
When nerve sensitization is identified as a significant component of knee pain, particularly the burning, electric, or diffuse quality of pain that does not fully resolve with structural treatment, perineural injection therapy (PIT) may be integrated alongside PRP or stem cell therapy. PIT targets the sensitized branches of the genicular and infrapatellar nerves that frequently contribute to chronic knee pain in OA, addressing the neurogenic component that structural treatments alone cannot resolve.
For patients with accompanying patellar tendinopathy, IT band involvement, or myofascial tension contributing to altered knee mechanics, extracorporeal shockwave therapy may also be incorporated. The combination is determined by the clinical picture, not by a standardized protocol.
Ready to Explore Non-Surgical Treatment for Your Knee?
Schedule a consultation with Dr. Bhandari to review your case, imaging, and history and to determine whether PRP, stem cell therapy, or a combined approach is the right fit for your knee.
Frequently Asked Questions
Cortisone injections are strong anti-inflammatory medicines that suppress the local inflammatory response to reduce pain in the short term, but repeated use can accelerate cartilage breakdown and weaken the tissues around the joint over time, the opposite of what a knee with osteoarthritis needs. Platelet-Rich Plasma works in the opposite manner, and rather than suppressing inflammation, it delivers a concentrated dose of the body's own growth factors directly into the knee joint, triggering an active healing cascade that may support cartilage repair, reduce synovial inflammation, and improve the joint environment. Injured tissues are given a signal to repair, instead of simply having their pain masked.
For knee osteoarthritis, many patients see meaningful improvement after one to two treatments, though the appropriate number depends on the severity of cartilage loss, the degree of synovial involvement, and the body's response to the initial injection. Dr. Bhandari determines this through a thorough assessment before any treatment is proposed, and will discuss a realistic plan for your specific case during the consultation.
PRP initiates a healing cascade rather than masking pain, so results develop gradually over weeks to months. Most patients begin noticing improvement within four to eight weeks of treatment, with continued improvement through the three-to-six-month window. Peak benefit is typically observed around three to six months post-treatment. Dr. Bhandari sets realistic, case-specific expectations during the initial consultation.
PRP is generally the starting point for mild to moderate knee osteoarthritis. Adipose-derived stem cell therapy is typically considered for more advanced cartilage loss, cases where PRP alone has not produced adequate improvement, or patients who want the broadest possible regenerative response. Because adipose-derived cellular therapy contains a diverse population of mesenchymal stem cells, perivascular cells, and immune-modulating factors, its biological reach extends beyond what PRP alone provides. Dr. Bhandari makes this determination based on clinical examination, imaging review, and overall case history.
The primary distinction from commercially marketed stem cell products is one of mislabeling: those products are typically donor-derived growth factor concentrates rather than true stem cell preparations. Dr. Bhandari's approach uses only the patient's own adipose tissue, harvested same day in the clinic. Adipose-derived cellular therapy contains several different cell types, growth factors, and other beneficial signaling molecules that an umbilical or embryonic commercial product cannot replicate.
Every patient begins with a thorough assessment that includes a detailed history, physical examination, and imaging review (X-ray and MRI where available). Because knee pain can be multifactorial, originating from the articular cartilage, subchondral bone, menisci, ligaments, periarticular tendons, or sensitized nerves, the specific pain generators are identified before any treatment is proposed. Dr. Bhandari also considers systemic contributors such as metabolic and inflammatory factors, consistent with an integrative naturopathic framework that looks beyond structural imaging alone. Lab testing is always ordered as part of this process.
Dr. Ashok Bhandari treats knee osteoarthritis at SageMED in Bellevue, WA. He is one of the few providers in the Greater Seattle area to combine lab-verified PRP dosing, highly concentrated and individualized PRP preparations, real-time ultrasound-guided injection delivery, and an integrative whole-person assessment for knee osteoarthritis.
To schedule a consultation or ask a question about your specific case, contact the clinic here.
Dr. Ashok Bhandari treats knee osteoarthritis with autologous adipose-derived stem cell therapy at SageMED in Bellevue, WA. He is one of the few providers in the Greater Seattle area to offer a same-day, in-office adipose harvest processed into MFAT and delivered under real-time ultrasound guidance, using only the patient's own tissue rather than a donor-derived commercial product.
To schedule a consultation or ask a question about your specific case, contact the clinic here.